Full View

Efficacy of RTS, S/AS01E vaccine against malaria in children 5 to 17 months of age

P Bejon, J Lusingu, A Olotu, A Leach… - … England Journal of …, 2008 - Mass Medical Soc
Background Plasmodium falciparum malaria is a pressing global health problem. A previous
study of the malaria vaccine RTS, S (which targets the circumsporozoite protein), given with …
被引用次数：534 相关文章

[引用][C] Efficacy of RTS, S/AS01E Vaccine against Malaria in Children 5 to 17 Months of Age

P BEJON, J LUSINGU, MA DEMOITIE… - The New England …, 2008 - pascal-francis.inist.fr
Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of Age CNRS
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …

Efficacy of RTS, S/AS01E vaccine against malaria in children 5 to 17 months of age.

P Bejon, J Lusingu, A Olotu… - The New England …, 2008 - researchonline.lshtm.ac.uk
BACKGROUND: Plasmodium falciparum malaria is a pressing global health problem. A
previous study of the malaria vaccine RTS, S (which targets the circumsporozoite protein) …

[引用][C] Efficacy of RTS, S/AS01E Vaccine against Malaria in Children 5 to 17 Months of Age

P Bejon, J Lusingu, A Olotu, A Leach… - New England Journal …, 2008 - cir.nii.ac.jp
Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of Age | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …

Efficacy of RTS, S/AS01E vaccine against malaria in children 5 to 17 months of age

P Bejon, J Lusingu, A Olotu, A Leach… - … England Journal of …, 2008 - research.ed.ac.uk
BACKGROUND: Plasmodium falciparum malaria is a pressing global health problem. A
previous study of the malaria vaccine RTS, S (which targets the circumsporozoite protein) …

Efficacy of RTS, S/AS01E vaccine against malaria in children 5 to 17 months of age

P Bejon, J Lusingu, A Olotu, A Leach… - … England Journal of …, 2008 - researchers.cdu.edu.au
Background: Plasmodium falciparum malaria is a pressing global health problem. A
previous study of the malaria vaccine RTS, S (which targets the circumsporozoite protein) …

Efficacy of RTS, S/AS01E vaccine against malaria in children 5 to 17 months of age.

P Bejon, J Lusingu, A Olotu, A Leach, M Lievens… - 2008 - cabidigitallibrary.org
BACKGROUND: Plasmodium falciparum malaria is a pressing global health problem. A
previous study of the malaria vaccine RTS, S (which targets the circumsporozoite protein) …

Efficacy of RTS, S/AS01E vaccine against malaria in children 5 to 17 months of age.

P Bejon, J Lusingu, A Olotu, A Leach… - New England journal …, 2008 - ora.ox.ac.uk
BACKGROUND: Plasmodium falciparum malaria is a pressing global health problem. A
previous study of the malaria vaccine RTS, S (which targets the circumsporozoite protein) …

Efficacy of RTS, S/AS01E vaccine against malaria in children 5 to 17 months of age

P Bejon, J Lusingu, A Olotu, A Leach… - The New England …, 2008 - pubmed.ncbi.nlm.nih.gov
Background Plasmodium falciparum malaria is a pressing global health problem. A previous
study of the malaria vaccine RTS, S (which targets the circumsporozoite protein), given with …
[HTML] nih.gov

[HTML][HTML] Efficacy of RTS, S/AS01E Vaccine against Malaria in Children 5 to 17 Months of Age

P Bejon, J Lusingu, A Olotu, A Leach… - The New England …, 2008 - ncbi.nlm.nih.gov
BACKGROUND Plasmodium falciparum malaria is a pressing global health problem. A
previous study of the malaria vaccine RTS, S (which targets the circumsporozoite protein) …